by Denise Purdie Andrews | Sep 5, 2023 | Announcements, Drug Classes
By George S. Behonick, Ph.D., F-ABFT, Laboratory Director, Chief Toxicologist Synthetic compounds designed to mimic the pharmacology of various illegal drug classes infiltrated the illicit drug market during the last decade plus; this includes synthetic cannabinoids...
by Denise Purdie Andrews | Aug 18, 2023 | Announcements, Drug Classes
By Kevin Shanks, M.S., D-ABFT-FT Novel psychoactive substances (NPS) are compounds designed or consumed to mimic the effects of typical recreational substances such as diacetylmorphine (heroin), cocaine, methamphetamine, cannabis, or even prescription medications. As...
by Denise Purdie Andrews | Jul 31, 2023 | Drug Classes
By Kevin Shanks, M.S., D-ABFT-FT As mentioned in the previous post, novel psychoactive substances (NPS) come in different flavors – and opioids, cannabinoids, stimulants, hallucinogens, and benzodiazepines are just a few of them. The Novel Emerging Compounds (NEC)...
by Denise Purdie Andrews | Jul 13, 2023 | Drug Classes
By Kevin Shanks, M.S., D-ABFT-FT Novel psychoactive substances (NPS) come in different varieties – opioids, cannabinoids, stimulants, hallucinogens, and benzodiazepines are just a few of the families on the illicit drug market. Axis developed the Novel Emerging...
by Denise Purdie Andrews | Jul 7, 2023 | Announcements, Drug Classes
Dear Valued Client, In the spirit of continuous improvement, to provide the most relevant panels and tests in the industry, our products are periodically updated to provide new and relevant offerings. It is with that goal in mind that we announce an update to our...
